Meanwhile, the expression of ESPL1, IQGAP3, RNASEH2A, AURKA, PRR11, PRC1, GAS2L3, CDCA8, and CEP55 was not significantly associated with the adverse prognosis of BC patients (Figure S1). Here, IQGAP3 is linked to breast cancer.